Results 101 to 110 of about 18,746 (183)

Representation learning of drug and disease terms for drug repositioning

, 2017
Drug repositioning (DR) refers to identification of novel indications for the approved drugs. The requirement of huge investment of time as well as money and risk of failure in clinical trials have led to surge in interest in drug repositioning.
Anand, Ashish, Manchanda, Sahil
core   +1 more source

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer’s disease in daily practice

Neuropsychiatric Disease and Treatment, 2012
Johannes Seibert1, Ferenc Tracik2,3, Konstantin Articus2, Stefan Spittler41Outpatient Clinic, Heidelberg, Germany; 2Novartis Pharma, Nürnberg, Germany; 3Department of Neurology, Heinrich-Heine University, Düsseldorf, Germany; 4Alexianer
Seibert J, Tracik F, Articus K, Spittler S   +3 more
doaj  

The evaluation of cognitive function in the dementias: methodological and regulatory considerations [PDF]

, 2018
This is the final version of the article. Available from the publisher via the NCBI link in this record.Impairment of cognitive function is the central feature of dementia. Although, clinically, the cognitive deficit most often manifests itself as memory
Harrison, JE, Wesnes, KA
core  

Adverse drug events affecting medication persistence with rivastigmine patch application

Patient Preference and Adherence, 2018
Takashi Osada,1 Norio Watanabe,1 Naomitsu Asano,2 Yuzo Adachi,2 Keiko Yamamura1 1Clinical Pharmacy, School of Pharmacy, Aichi Gakuin University, Nagoya, Aichi, Japan; 2Sasayuri Pharmacy, Toki, Gifu, Japan Purpose: The rivastigmine transdermal patch ...
Osada T, Watanabe N, Asano N, Adachi Y, Yamamura K   +4 more
doaj  

Determination of Alzheimer’s Drugs in a Human Urine Sample by Different Chemometric Methods

International Journal of Analytical Chemistry
In this study, spectrophotometric determination of donepezil and rivastigmine in healthy human urine samples was carried out by the statistical method.
Güzide Pekcan
doaj   +1 more source

Movement disorders associated with acetylcholinesterase inhibitors in Alzheimer’s dementia: A systematic review

Brain Circulation
BACKGROUND: Acetylcholinesterase inhibitors (AChEIs) are widely used in Alzheimer’s disease (AD). This study aims to systematically review the literature about movement disorders (MDs) associated with AChEIs for AD, which include donepezil, galantamine ...
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara   +1 more
doaj   +1 more source

Cognitive and behavioural predictors of survival in Alzheimer disease:results from a sample of treated patients in a tertiary-referral memory clinic [PDF]

, 2012
Agüero-Torres, Andersen, Brandt, Brookmeyer, Buchner, Cox, Cummings, Doody, Ferri, Folstein, Gambassi, General Register Office for Scotland, Helmer, Hicks, Hötte, Inouye, ISD Scotland, Kaplan, Knopman, Landi, Larson, Lawton, Lezak, Luchsinger, Martyn, McGurn, McKhann, Mental Welfare Commission for Scotland, Mielke, Miller, Morgan, Musicco, Nelson, Newcomer, Rait, Reisberg, Richards, Robbins, Scarmeas, Scarmeas, Schneider, Sinforiani, Solfrizzi, SPSS Inc, Starr, Starr, Starr, Starr, Stern, Stern, Stern, Stern, Thomas, Tsai, Tun, Van Dijk, Wang, Whalley, Whitmer, Wolfson   +59 more
core   +1 more source

Antimuscarinic Toxicity Safely Managed with High-Dose Transdermal Rivastigmine: A Case Report. [PDF]

Clin Pract Cases Emerg Med
Watson CJ, Burrill EM, Jaffee WS.
europepmc   +1 more source

Effects of hydromethylthionine mesylate and rivastigmine in a pharmacological mouse model of Alzheimer's disease. [PDF]

Behav Pharmacol
Robinson L, Bray J, Melis V, Harrington CR, Wischik CM, Riedel G.   +5 more
europepmc   +1 more source

Switching from Oral Cholinesterase Inhibitors to a Transdermal Donepezil Patch Attenuated Gastrointestinal Symptoms and Allowed Treatment Continuation in Three Patients with Alzheimer's Disease in Clinical Settings. [PDF]

Brain Sci
Motoi Y, Sanjo N.
europepmc   +1 more source